Patent 7482373 was granted and assigned to Icagen, Inc. on January, 2009 by the United States Patent and Trademark Office.
The present invention provides a genus of bis-benzimidazole compounds, methods and pharmaceutical compositions that are useful as modulators of potassium ion channels. The compounds of the invention are of use in both therapeutic and diagnostic methods.